Certified by Founder Lodge
Iktos
France - Paris
START UP
1 Disclosed Funding Rounds $16,428,000
0 Participating Investments
-
Founded date
2016
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
We are Iktos. A start-up company specializing in the development of proprietary artificial intelligence technologies and software for ligand-based and structure-based de novo drug design focu
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 10 ,2023 | Series A | $16,428,000 |
Omnes
M Ventures
Debiopharm
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
